My Cart

ILDR2

ILDR2 Overview

English NameImmunoglobulin-like domain-containing receptor 2Approved Drugs0
Drugs in Clinical Trials1Target SynonymImmunoglobulin-like domain-containing receptor 2,ILDR2,C1orf32,Immunoglobulin-Like Domain Containing Receptor 2,LISCH-Like,DJ782G3.1,Immunoglobulin Like Domain Containing Receptor 2,Chromosome 1 Open Reading Frame 32
Highest Development StagePhase 1 Clinical
English NameImmunoglobulin-like domain-containing receptor 2
Target SynonymImmunoglobulin-like domain-containing receptor 2,ILDR2,C1orf32,Immunoglobulin-Like Domain Containing Receptor 2,LISCH-Like,DJ782G3.1,Immunoglobulin Like Domain Containing Receptor 2,Chromosome 1 Open Reading Frame 32
Approved Drugs0
Drugs in Clinical Trials1
Highest Development StagePhase 1 Clinical

ILDR2 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    Fc Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeatureOrder Now
IL2-H5259
Human
HEK293
Human ILDR2 Protein, Fc Tag
Add to Cart
Total: 1
  • 1

ILDR2 Background

ILDR2 belongs to the immunoglobulin superfamily. May be involved in lipid homeostasis and ER stress pathways. ILDR2 as a novel B7-like protein with robust T cell inhibitory activity, expressed in immune cells and in immune-privileged and inflamed tissues. A fusion protein, consisting of ILDR2 extracellular domain with an Fc fragment, that binds to a putative counterpart on activated T cells showed a beneficial effect in the collagen-induced arthritis model and abrogated the production of proinflammatory cytokines and chemokines in autologous synovial-like cocultures of macrophages and cytokine-stimulated T cells. Collectively, these findings point to ILDR2 as a novel negative regulator for T cells, with potential roles in the development of immune-related diseases, including autoimmunity and cancer.

ILDR2 Synonyms

ILDR2,C1orf32

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
BapotulimabBAY-1905254Phase 1 ClinicalCompugen LtdSolid tumours; Squamous Cell Carcinoma of Head and Neck
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland